Department of Ophthalmology, UZLeuven
Leuven, Belgium
NCT Number: NCT01788319
This study will investigate if micropulse laser trabeculoplasty (532nm) is as effecttive as or better than the conventional laser trabeculoplasty (532nm), it might be a new treatment strategy for glaucoma patients. It is done with a laser device that can also be used for many other ophthalmic applications, thus reducing the economic burden of treatment.
Looking for future studies?
Notify Me18 year–90 year
All sexes
Interventional
Not applicable
Leuven, Belgium
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Other names: Conventional (532nm)
Time frame: one year of follow-up
Time frame: one year of follow up
Universitaire Ziekenhuizen KU Leuven
Other
Micropulse Laser Trabeculoplasty (532nm) Versus Conventional Laser Trabeculoplasty (532nm) in Open Angle Glaucoma Patients
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07082816
Eye Diseases, Glaucoma
Dothan, Alabama, United States
View Trial DetailsNCT06441643
Eye Diseases, Glaucoma
Garden Grove, California, United States
View Trial DetailsNCT05938699
Eye Diseases, Glaucoma
Rochester, Minnesota, United States
View Trial DetailsNCT04773106
Eye Diseases, Glaucoma
Bochum, Germany
View Trial Details